Validation of a French version of the QUALIDEM scale, an external quality of life instrument
Revue de gériatrie · 2022
DOI: 10.62581/revgeri.17850 ↗Abstract
Backgroung: One of the possible ways to assess the quality of life (QOL) of persons with neurocognitive disorders is to use external evaluation scales. The QUALIDEM scale, a multidimensional QOL instrument is one of them but there is no validated version translated into French to date. The aim of this study was therefore to validate the French version of this scale. Methods: A cross-sectional observational study carried out with residents of various nursing homes (NH) in our area. A French translation of the QUALIDEM scale was compared to the “Quality of Life in Alzheimer’s Disease scale (QOL-AD)” to assess the residents’ QOL measured by the healthcare teams. The content validity of the QUALIDEM scale was estimated by correlating its score with the scores of the QOL-AD scale. The internal consistency was estimated by calculating Cronbach’s a coefficient. Results: The study ran from May to November 2020. During this period, 446 residents were assessed according to the inclusion criteria in 7 NH. The QOL estimated by the QUALIDEM scale was 72.5±18.6 in the group with GDS score of 1-6 and 28.6±8.6 in the group with GDS>6. The three lowest subscale scores were those of positive affect (4.0), social relations (4.1) and ability to care (3.1). Conclusion: The precise evaluations which were carried out by the QUALIDEM scale reflected quality of life of residents that were consistent with what one might expect but not detectable with an overall score of quality of life. QUALIDEM scale seems to be a suitable multidimensional instrument for residents with severe neurocognitive disorders, though further validation work is encouraged.
EUVIMED